Merck lost U.S. market exclusivity for its cholesterol drug Zetia. "Merck Revenue Declines As Generic Competition Hurts Results," at 7:47 a.m. ET, misspelled Zetia in the 3rd paragraph. (Feb. 2)

(END) Dow Jones Newswires

February 02, 2017 11:37 ET (16:37 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merck Charts.